What is it about?
The editorial describes our current challenges of defining quiescent and active inflammation in ANCA kidney disease, the results of the PRE-FLARE study investigating urinary cells as biomarkers and the future perspective of using new diagnostic techniques to advance our clinical practice.
Featured Image
Read the Original
This page is a summary of: The Challenge of Assessing Remission and Relapse in ANCA Kidney Disease, Journal of the American Society of Nephrology, March 2024, Wolters Kluwer Health,
DOI: 10.1681/asn.0000000000000331.
You can read the full text:
Contributors
The following have contributed to this page
